Current role of cardiac biomarkers in extra-cardiac diseases in children-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current role of cardiac biomarkers in extra-cardiac diseases in children

Published:2020-09 Issue:13 Volume:14 Page:1183-1187
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Rodriguez-Gonzalez Moises¹²^ORCID,A Perez-Reviriego Alvaro¹²,Castellano-Martinez Ana³²

Affiliation:

1. Pediatric Cardiology Department of Puerta del Mar University Hospital, Cadiz, Spain

2. Biomedical Research & Innovation Institute of Cadiz (INiBICA), Research Unit, Puerta del Mar University Hospital, University of Cadiz, Spain

3. Pediatric Nephrology Department of Puerta del Mar University Hospital, Cadiz, Spain

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

Link

https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2020-0232

Reference25 articles.

1. Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines

2. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT

3. Distribution of circulating cardiac biomarkers in healthy children: from birth through adulthood

4. NT-proBNP plasma levels as biomarkers for pulmonary hypertension in healthy infants with respiratory syncytial virus infection

5. Left Ventricular Dysfunction and Plasmatic NT-proBNP Are Associated with Adverse Evolution in Respiratory Syncytial Virus Bronchiolitis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of high-sensitivity cardiac troponin I reference interval for a hospitalized paediatric population under improved selection criteria in the Shandong area;Journal of Laboratory Medicine;2024-01-01

2. NT-PROBNP as a screening tool for low-risk patent ductus arteriousus: a follow-up validation study;European Journal of Pediatrics;2023-09-29

3. Nt-probnp as a Screening for Low-risk Patent Ductus Arteriousus: a Follow-up Validation Study;2023-08-31

4. Review for best practice in clinical rheumatology juvenile systemic sclerosis – Updates and practice points;Best Practice & Research Clinical Rheumatology;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3